G
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Price:
31.13
CNY
-2.01%
Market Closed
Market Cap:
¥12.5B
Income Statement
Earnings Waterfall
Guangdong Marubi Biotechnology Co Ltd
Guangdong Marubi Biotechnology Co Ltd
Income Statement
Guangdong Marubi Biotechnology Co Ltd
Guangdong Marubi Biotechnology Co Ltd
Currency: CNY
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
2
|
3
|
5
|
6
|
6
|
7
|
6
|
5
|
4
|
10
|
9
|
0
|
0
|
|
| Revenue |
1 576
N/A
|
1 606
+2%
|
1 662
+4%
|
1 732
+4%
|
1 801
+4%
|
1 807
+0%
|
1 780
-1%
|
1 727
-3%
|
1 745
+1%
|
1 779
+2%
|
1 825
+3%
|
1 745
-4%
|
1 787
+2%
|
1 766
-1%
|
1 730
-2%
|
1 793
+4%
|
1 732
-3%
|
1 826
+5%
|
1 974
+8%
|
2 124
+8%
|
2 226
+5%
|
2 410
+8%
|
2 518
+4%
|
2 641
+5%
|
2 970
+12%
|
3 155
+6%
|
3 387
+7%
|
3 468
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
(503)
|
(530)
|
(549)
|
(571)
|
(579)
|
(599)
|
(592)
|
(574)
|
(596)
|
(628)
|
(667)
|
(669)
|
(655)
|
(647)
|
(606)
|
(608)
|
(557)
|
(594)
|
(638)
|
(654)
|
(665)
|
(694)
|
(699)
|
(721)
|
(793)
|
(843)
|
(917)
|
(940)
|
|
| Gross Profit |
1 073
N/A
|
1 076
+0%
|
1 113
+3%
|
1 161
+4%
|
1 222
+5%
|
1 208
-1%
|
1 188
-2%
|
1 153
-3%
|
1 149
0%
|
1 151
+0%
|
1 158
+1%
|
1 076
-7%
|
1 133
+5%
|
1 118
-1%
|
1 124
+1%
|
1 185
+5%
|
1 175
-1%
|
1 232
+5%
|
1 336
+9%
|
1 470
+10%
|
1 560
+6%
|
1 716
+10%
|
1 820
+6%
|
1 921
+6%
|
2 177
+13%
|
2 312
+6%
|
2 470
+7%
|
2 528
+2%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(621)
|
(602)
|
(598)
|
(582)
|
(656)
|
(660)
|
(650)
|
(652)
|
(668)
|
(698)
|
(762)
|
(809)
|
(890)
|
(914)
|
(953)
|
(955)
|
(1 013)
|
(1 053)
|
(1 147)
|
(1 258)
|
(1 371)
|
(1 492)
|
(1 569)
|
(1 639)
|
(1 826)
|
(1 927)
|
(2 099)
|
(2 188)
|
|
| Selling, General & Administrative |
(619)
|
(606)
|
(628)
|
(614)
|
(643)
|
(644)
|
(628)
|
(633)
|
(653)
|
(680)
|
(730)
|
(765)
|
(856)
|
(872)
|
(897)
|
(903)
|
(975)
|
(1 014)
|
(1 106)
|
(1 213)
|
(1 320)
|
(1 440)
|
(1 510)
|
(1 581)
|
(1 757)
|
(1 852)
|
(2 029)
|
(2 116)
|
|
| Research & Development |
(34)
|
(34)
|
(35)
|
(37)
|
(45)
|
(46)
|
(51)
|
(52)
|
(50)
|
(52)
|
(51)
|
(53)
|
(50)
|
(52)
|
(51)
|
(49)
|
(53)
|
(53)
|
(57)
|
(60)
|
(62)
|
(65)
|
(69)
|
(72)
|
(74)
|
(73)
|
(78)
|
(82)
|
|
| Depreciation & Amortization |
(8)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
40
|
39
|
65
|
69
|
40
|
30
|
28
|
33
|
43
|
34
|
19
|
10
|
27
|
10
|
(5)
|
(3)
|
24
|
14
|
17
|
14
|
19
|
13
|
11
|
14
|
17
|
(1)
|
9
|
10
|
|
| Operating Income |
451
N/A
|
474
+5%
|
516
+9%
|
579
+12%
|
565
-2%
|
548
-3%
|
538
-2%
|
500
-7%
|
481
-4%
|
453
-6%
|
396
-13%
|
267
-32%
|
242
-9%
|
204
-16%
|
171
-16%
|
230
+34%
|
161
-30%
|
179
+11%
|
189
+6%
|
212
+12%
|
189
-11%
|
225
+19%
|
251
+12%
|
282
+12%
|
351
+25%
|
385
+10%
|
371
-4%
|
340
-8%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
33
|
36
|
43
|
55
|
56
|
71
|
92
|
99
|
92
|
86
|
62
|
50
|
54
|
57
|
54
|
58
|
46
|
46
|
43
|
38
|
133
|
127
|
129
|
128
|
30
|
32
|
26
|
58
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
2
|
1
|
1
|
1
|
(4)
|
(3)
|
(5)
|
(5)
|
(0)
|
11
|
10
|
11
|
11
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
(0)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
486
N/A
|
512
+5%
|
560
+9%
|
635
+13%
|
614
-3%
|
616
+0%
|
627
+2%
|
594
-5%
|
567
-5%
|
539
-5%
|
468
-13%
|
328
-30%
|
310
-6%
|
273
-12%
|
225
-17%
|
288
+28%
|
207
-28%
|
224
+8%
|
232
+4%
|
250
+8%
|
317
+27%
|
351
+11%
|
379
+8%
|
408
+8%
|
381
-7%
|
417
+10%
|
397
-5%
|
397
+0%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
(74)
|
(76)
|
(88)
|
(99)
|
(101)
|
(104)
|
(101)
|
(101)
|
(104)
|
(96)
|
(87)
|
(66)
|
(68)
|
(67)
|
(56)
|
(68)
|
(39)
|
(41)
|
(47)
|
(23)
|
(39)
|
(41)
|
(55)
|
(66)
|
(38)
|
(50)
|
(45)
|
(48)
|
|
| Income from Continuing Operations |
412
|
436
|
472
|
536
|
513
|
512
|
526
|
494
|
463
|
444
|
381
|
262
|
241
|
206
|
169
|
220
|
167
|
182
|
185
|
227
|
278
|
309
|
323
|
343
|
342
|
367
|
351
|
349
|
|
| Income to Minority Interest |
3
|
3
|
5
|
3
|
2
|
0
|
0
|
0
|
1
|
2
|
5
|
6
|
7
|
7
|
7
|
6
|
7
|
5
|
3
|
1
|
(18)
|
(18)
|
(18)
|
(18)
|
(1)
|
(1)
|
(1)
|
(3)
|
|
| Net Income (Common) |
415
N/A
|
440
+6%
|
477
+8%
|
538
+13%
|
515
-4%
|
513
0%
|
527
+3%
|
494
-6%
|
464
-6%
|
446
-4%
|
385
-14%
|
268
-30%
|
248
-8%
|
213
-14%
|
176
-18%
|
226
+28%
|
174
-23%
|
187
+8%
|
188
+0%
|
228
+21%
|
259
+14%
|
291
+12%
|
305
+5%
|
324
+6%
|
342
+5%
|
366
+7%
|
351
-4%
|
347
-1%
|
|
| EPS (Diluted) |
1.15
N/A
|
1.22
+6%
|
1.32
+8%
|
1.36
+3%
|
1.37
+1%
|
1.28
-7%
|
1.33
+4%
|
1.24
-7%
|
1.16
-6%
|
1.11
-4%
|
0.96
-14%
|
0.67
-30%
|
0.62
-7%
|
0.53
-15%
|
0.44
-17%
|
0.57
+30%
|
0.43
-25%
|
0.47
+9%
|
0.47
N/A
|
0.57
+21%
|
0.65
+14%
|
0.73
+12%
|
0.76
+4%
|
0.81
+7%
|
0.85
+5%
|
0.91
+7%
|
0.87
-4%
|
0.86
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
